BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 221514)

  • 1. Effects of butyrate and dibutyryl cyclic AMP on hCG-secreting trophoblastic and non-trophoblastic cells.
    Hussa RO; Pattillo RA; Ruckert AC; Scheuermann KW
    J Clin Endocrinol Metab; 1978 Jan; 46(1):69-76. PubMed ID: 221514
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of dibutyryl cyclic AMP and epidermal growth factor on the synthesis and secretion of human chorionic gonadotropin and its subunits by trophoblastic and non-trophoblastic cells.
    Futamura K; Maruo T; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Sep; 39(9):1641-8. PubMed ID: 2824633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of synthesis and secretion of chorionic gonadotropin subunits by eutopic and ectopic hormone-producing human cell lines.
    Ruddon RW; Anderson C; Meade-Cobun KS
    Cancer Res; 1980 Dec; 40(12):4519-23. PubMed ID: 6254647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of somatostatin to affect human chorionic somatomammotropin and human chorionic gonadotropin secretion in vitro.
    Macaron C; Kyncl M; Rutsky L; Halpern B; Brewer J
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1141-3. PubMed ID: 45471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent dibutyryl cyclic adenosine monophosphate stimulation of human chorionic gonadotropin and estrogen secretion by malignant trophoblast cells in vitro.
    Story MT; Hussa RO; Pattillo RA
    J Clin Endocrinol Metab; 1974 Nov; 39(5):877-81. PubMed ID: 4371458
    [No Abstract]   [Full Text] [Related]  

  • 6. Actions of cyclic AMP, its butyryl derivatives and Na butyrate on the HCG output of malignant trophoblast cells in vitro.
    Barker H; Isles TE
    Br J Cancer; 1978 Jul; 38(1):158-62. PubMed ID: 210779
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on variations in hCG levels following treatment of trophoblastic tumors, with special reference to criteria governing their typing and remission (author's transl)].
    Sugita S
    Nihon Gan Chiryo Gakkai Shi; 1976 Mar; 11(1):16-22. PubMed ID: 182886
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of human chorionic gonadotropin (hCG) secretion by serum and dibutyryl cyclic AMP in malignant trophoblast cells in vitro.
    Hussa RO; Story MT; Pattillo RA
    J Clin Endocrinol Metab; 1975 Mar; 40(3):401-5. PubMed ID: 163842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [b-HCG secretion of non-trophoblastic uterine cancer].
    Keramopoullos A; Michalas S; Papapetrou P; Kaskarelis D
    Arch Gynecol; 1979 Jul; 228(1-4):662-3. PubMed ID: 485548
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of the synthesis of human chorionic gonadotrophin by 5-bromo-2'-deoxyuridine and dibutyryl cyclic AMP in trophoblastic and nontrophoblastic tumor cells.
    Chou JY; Wang SS; Robinson JC
    J Clin Endocrinol Metab; 1978 Jul; 47(1):46-51. PubMed ID: 233662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential modulation of human chorionic gonadotropin secretion by epidermal growth factor in normal and malignant placental cultures.
    Huot RI; Foidart JM; Nardone RM; Stromberg K
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1059-63. PubMed ID: 7026593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific binding sites for epidermal growth factor and its effect on human chorionic gonadotrophin secretion by cultured tumour cell lines: comparison between trophoblastic and non-trophoblastic cells.
    Hirata Y; Sueoka S; Uchihashi M; Yoshimoto Y; Fujita T; Matsukura S; Motoyama T
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):281-6. PubMed ID: 6291299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic and physical characterization of human chorionic gonadotropin and its subunits in cultures of human malignant trophoblast.
    Hussa RO
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1154-62. PubMed ID: 194911
    [No Abstract]   [Full Text] [Related]  

  • 14. [Modification of hCG secretion by biological modulators of cell response and cytostatics in the normal placenta and choriocarcinoma cells].
    Marth C; Brattia M; Müller-Holzner E; Tabarelli M; Daxenbichler G
    Gynakol Rundsch; 1988; 28 Suppl 2():62-3. PubMed ID: 3069634
    [No Abstract]   [Full Text] [Related]  

  • 15. Endocrine aspects of trophoblastic neoplasia.
    Clayton LA; Tyrey L; Weed JC; Hammond CB
    J Reprod Med; 1981 Apr; 26(4):192-9. PubMed ID: 6260934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of gestational trophoblastic disease].
    Germá Lluch JR
    Med Clin (Barc); 1981 Apr; 76(7):327-30. PubMed ID: 6265718
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidermal growth factor stimulates secretion of human chorionic gonadotropin by cultured human choriocarcinoma cells.
    Benveniste R; Speeg KV; Carpenter G; Cohen S; Lindner J; Rabinowitz D
    J Clin Endocrinol Metab; 1978 Jan; 46(1):169-72. PubMed ID: 312807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential modulation of human chorionic gonadotropin production by methotrexate in normal and malignant placental cultures and its increase by dibutyryl cyclic adenosine monophosphate and/or actinomycin D in normal cultures.
    Huot RI; Nardone RM; Stromberg K
    Cancer Res; 1987 Jan; 47(2):383-7. PubMed ID: 3024820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early stimulation of human chorionic gonadotropin secretion by dibutyryl cyclic AMP and theophylline in human malignant trophoblast cells in vitro: inhibition by actinomycin D, alpha-amanitin, and cordycepin.
    Pattillo RA; Hussa O
    Gynecol Invest; 1975; 6(6):365-77. PubMed ID: 174977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of adenosine cyclic nucleotides on the synthesis of human chorionic gonadotropin in transformed human placental cells.
    Chou JY
    Cancer Res; 1980 Nov; 40(11):4025-30. PubMed ID: 6162542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.